# Warfarin Versus Aspirin Recurrent Stroke Study

> **NCT00027066** · PHASE3 · COMPLETED · sponsor: **Columbia University** · enrollment: 2206 (—)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Active Aspirin
- **DRUG:** Active Warfarin
- **DRUG:** Aspirin placebo
- **DRUG:** Warfarin placebo

## Key facts

- **NCT ID:** NCT00027066
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-06
- **Primary completion:** 2000-06
- **Final completion:** 2001-11
- **Target enrollment:** 2206 (—)
- **Last updated:** 2011-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00027066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00027066, "Warfarin Versus Aspirin Recurrent Stroke Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00027066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*